Premium
Cutaneous sıde‐effects of the potential COVID‐19 drugs
Author(s) -
Türsen Ümit,
Türsen Belma,
Lotti Torello
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13476
Subject(s) - hydroxychloroquine , medicine , lopinavir , covid-19 , ritonavir , lopinavir/ritonavir , pharmacology , chloroquine , dermatology , virology , disease , immunology , virus , infectious disease (medical specialty) , viral load , malaria , outbreak , antiretroviral therapy
COVID‐19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon‐beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side‐effects of these drugs.